Xortx Therapeutics Company
XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease with secondary programs focused on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. At XORTX Therapeutics, they are dedicated to developing medications to improve the quality of life and future health of patients.
Industry:
PharmTech
Headquarters:
Calgary, Alberta, Canada
Zip:
11-50
Founded Date:
2012-01-01
Employees Number:
11-50
Investors Number:
6000000
Total Funding:
$1M to $10M
Estimated Revenue:
2020-12-29
Last Funding Date:
Post-IPO Equity
Last Funding Type:
info@xortx.com
Register and Claim Ownership